Skip to main content
. 2009 Nov 16;27(36):6101–6108. doi: 10.1200/JCO.2009.22.2554

Table 4.

Toxicity

Parameter Treatments 1, 2, and 2.5(n = 78)
Treatment 3(n = 69)
Treatment 4(n = 67)
No. % No. % No. %
No. of days for ANC < 500/μL
    Median 5 10 9
    Range 0-16 0-16 0-39
No. of days for platelets < 20,000/μL
    Median 0 7 6
    Range 0-52 0-20 0-170
No. of platelet transfusions
    Median 0 7 3
    Range 0-21 0-37 0-36
No. of RBC units transfused
    Median 0 4 2
    Range 0-23 0-11 0-22
Days of hospitalization
    Median 9 13 20
    Range 0-39 3-31 0-67
No. of days of TPN
    Median 0 0 0
    Range 0-0 0-6 0-15
No. of days of IV narcotics
    Median 0 0 0
    Range 0-6 0-11 0-61
Maximum total bilirubin, mg/dL
    Median 0.8 0.9 0.9
    Range 0.2-2.8 0.2-4.7 0.3-5.8
Maximum alkaline phosphatase, IU/L
    Median 113 106 109
    Range 40-371 10-552 50-351
Maximum creatinine, mg/dL
    Median 1.1 1.1 1.1
    Range 0.7-5.5 0.7-2.9 0.7-3.2
Needed platelet transfusion 13 17 67 97 61 91
Needed RBC transfusion 25 32 69 93 54 82
Needed hospitalization 76 99 69 100 65 97
Needed TPN 0 0 3 4 9 13
Needed IV narcotics 14 18 24 35 30 45
≥ Grade 3 (NCI common toxicity criteria)
    GI 10 13 15 22 17 25
    Hepatic 0 0 5 7 3 4
    Pulmonary 2 3 2 3 1 1
    Cardiac 4 5 3 4 4 6
    Cutaneous 1 1 6 9 0 0
    Infection 9 12 21 30 19 28
    Febrile neutropenia 12 15 28 41 24 36
    CNS 0 0 3 4 0 0
    Peripheral nervous system 0 0 0 0 0 0
    Metabolic (Cr) 2 2.5 0 0 0 0

Abbreviations: ANC, absolute neutrophil count; RBC, red blood cells; TPN, total parenteral nutrition; IV, intravenous; IU/L, international units per liter; NCI, National Cancer Institute; Cr, serum creatinine.